Personal information

Activities

Employment (1)

Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences: Beijing, Beijing, CN

(Department of Medical Oncology)
Employment
Source: Self-asserted source
Jiangyong Yu

Education and qualifications (1)

Peking University: Beijing, Beijing, CN

2012-09-01 to 2015-07-15 | Doctor (Department of Medical Oncology)
Education
Source: Self-asserted source
Jiangyong Yu

Funding (2)

National Natural Sciences Foundation of China

2022-01 to 2024-12 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Jiangyong Yu

National Natural Sciences Foundation of China

2020-01 to 2023-12 | Grant
National Natural Science Foundation of China (Beijing, CN)
Source: Self-asserted source
Jiangyong Yu

Works (12)

Efficacy and safety of immunotherapy combined with chemotherapy in patients with ES‐SCLC: A systematic review and network meta‐analysis of RCTs and RWSs

Thoracic Cancer
2024-11 | Journal article
Contributors: Runting Kang; Junling Ma; Bin Ai; Juanjuan Liu; Zitong Zheng; Jiangyong Yu
Source: check_circle
Crossref

Advances in new targets for immunotherapy of small cell lung cancer

Thoracic Cancer
2024-01 | Journal article
Contributors: Zitong Zheng; Juanjuan Liu; Junling Ma; Runting Kang; Zhen Liu; Jiangyong Yu
Source: check_circle
Crossref

Whole exome analysis reveals the genomic profiling related to chemo‐resistance in Chinese population with limited‐disease small cell lung cancer

Cancer Medicine
2023-01 | Journal article
Contributors: Jiangyong Yu; Shuangtao Zhao; Zhe Su; Chengli Song; Lihong Wu; Jingbo Wang; Nan Bi; Lvhua Wang
Source: check_circle
Crossref

TP53 and LRP1B Co-Wild Predicts Improved Survival for Patients with LUSC Receiving Anti-PD-L1 Immunotherapy

Cancers
2022-07-12 | Journal article
Contributors: Jiangyong Yu; Zaiwen Fan; Zhipeng Zhou; Ping Zhang; Jing Bai; Xu Li; Min Tang; Nannan Fan; Xiaonan Wu; Xin Nie et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Efficacy and safety of anti<scp>‐PD</scp>‐1/<scp>PD‐L1</scp> in combination with chemotherapy or not as first‐line treatment for advanced non‐small cell lung cancer: A systematic review and network meta‐analysis

Thoracic Cancer
2022-02 | Journal article
Part of ISSN: 1759-7706
Part of ISSN: 1759-7714
Contributors: Liming Wang; Yifan Yang; Jiangyong Yu; Shuai Zhang; Xu Li; Xiaonan Wu; Xin Nie; Wenbo Liu; Ping Zhang; Yi Li et al.
Source: Self-asserted source
Jiangyong Yu

Expression of p42.3 in non-small cell lung cancer

Annals of Translational Medicine
2020-07 | Journal article
Part of ISSN: 2305-5839
Part of ISSN: 2305-5847
Contributors: Xinmu Zhang; Xin Nie; Junyu Long; Jiangyong Yu; Ping Zhang; Yan Liu; Xiaonan Wu; Yi Bai; Jinzhu Mao; Xiaochuan Liu et al.
Source: Self-asserted source
Jiangyong Yu

Clinical characteristics and prognosis of pulmonary large cell carcinoma: A population‐based retrospective study using <scp>SEER</scp> data

Thoracic Cancer
2020-06 | Journal article
Part of ISSN: 1759-7706
Part of ISSN: 1759-7714
Contributors: Liu Xiaochuan; Yu Jiangyong; Zhang Ping; Wu Xiaonan; lin li
Source: Self-asserted source
Jiangyong Yu

Inferring the Evolution and Progression of Small-Cell Lung Cancer by Single-Cell Sequencing of Circulating Tumor Cells

Clinical Cancer Research
2019-08-15 | Journal article
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Contributors: Zhe Su; Zhijie Wang; Xiaohui Ni; Jianchun Duan; Yan Gao; Minglei Zhuo; Ruoyan Li; Jun Zhao; Qi Ma; Hua Bai et al.
Source: Self-asserted source
Jiangyong Yu

TBX21 predicts prognosis of patients and drives cancer stem cell maintenance via the TBX21–IL-4 pathway in lung adenocarcinoma

Stem Cell Research &amp; Therapy
2018-12 | Journal article
Part of ISSN: 1757-6512
Contributors: Shuangtao Zhao; Wenzhi Shen; Jiangyong Yu; Luhua Wang
Source: Self-asserted source
Jiangyong Yu

Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer

Clinical Cancer Research
2018-05-01 | Journal article
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Contributors: Jiangyong Yu; Shuhang Wang; Wei Zhao; Jianchun Duan; Zhijie Wang; Hanxiao Chen; Yanhua Tian; Di Wang; Jun Zhao; Tongtong An et al.
Source: Self-asserted source
Jiangyong Yu

Machine Learning Based Prediction of Brain Metastasis of Patients with IIIA-N2 Lung Adenocarcinoma by a Three-miRNA Signature

Translational Oncology
2018-02 | Journal article
Part of ISSN: 1936-5233
Contributors: Shuangtao Zhao; Jiangyong Yu; Luhua Wang
Source: Self-asserted source
Jiangyong Yu

Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21

Chinese Journal of Cancer
2016-12 | Journal article
Part of ISSN: 1944-446X
Contributors: Jiang-Yong Yu; Si-Fan Yu; Shu-Hang Wang; Hua Bai; Jun Zhao; Tong-Tong An; Jian-Chun Duan; Jie Wang
Source: Self-asserted source
Jiangyong Yu